| |
|
| |
 |
|
| Aberdare Ventures |
|
| Essex Investment Management Company |
|
| Fidelity Biosciences Group |
|
| GGV Capital |
|
| Invus, LP |
|
| Jennison Associates |
|
| Maverick Capital |
|
| Morgan Stanley Investment Management |
|
| Polaris Venture Partners |
|
| Ridgeback Capital Management LLC |
|
| Venrock Associates |
|
To date, Ironwood Pharmaceuticals has
raised $321 million of equity capital. |
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
